Evidence map›Paper›PMID 27585950›Full record

ArticleScientific reports2016

Osteoblasts secrete miRNA-containing extracellular vesicles that enhance expansion of human umbilical cord blood cells.

Jess Morhayim, Jeroen van de Peppel, Eric Braakman, Elwin W J C Rombouts, Mariette N D Ter Borg, Amel Dudakovic, Hideki Chiba, Bram C J van der Eerden, Marc H Raaijmakers, Andre J van Wijnen and 2 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
0.9field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 34 citations in OpenAlex.

  1. Review
  2. Article
  3. Niche-derived exosomes controlFrontiers in immunology · 2026
    Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Identification of osteolineage cell-derived extracellular vesicle cargo implicated in hematopoietic support.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2020
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 3 countries.

Jess MorhayimDepartment of Internal Medicine, Erasmus Medical Center, Rotterdam, the Netherlands.
Jeroen van de PeppelDepartment of Internal Medicine, Erasmus Medical Center, Rotterdam, the Netherlands.
Eric BraakmanDepartment of Hematology, Erasmus Medical Center, Rotterdam, the Netherlands.
Elwin W J C RomboutsDepartment of Hematology, Erasmus Medical Center, Rotterdam, the Netherlands.
Mariette N D Ter BorgDepartment of Hematology, Erasmus Medical Center, Rotterdam, the Netherlands.
Amel DudakovicDepartment of Orthopedic Surgery, Mayo Clinic, Rochester, MN, USA.
Hideki ChibaFukushima Medical University School of Medicine, Hikarigaoka, 960-1295, Fukushima, Japan.
Bram C J van der EerdenDepartment of Internal Medicine, Erasmus Medical Center, Rotterdam, the Netherlands.
Marc H RaaijmakersDepartment of Hematology, Erasmus Medical Center, Rotterdam, the Netherlands.
Andre J van WijnenDepartment of Orthopedic Surgery, Mayo Clinic, Rochester, MN, USA.
Jan J CornelissenDepartment of Hematology, Erasmus Medical Center, Rotterdam, the Netherlands.
Johannes P van LeeuwenDepartment of Internal Medicine, Erasmus Medical Center, Rotterdam, the Netherlands.
Erasmus MC · NLMayo Clinic in Arizona · USFukushima Medical University · JP

Funding

Molecular Control of Bone FormationR01AR049069 · NIAMS · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI WESTENDORF, JENNIFER J · 2003 to 2021
$5.8M
Epigenetic control of osteoblast differentiationF32AR066508 · NIAMS · MAYO CLINIC ROCHESTER · PI DUDAKOVIC, AMEL · 2015 to 2017
$185k
NIAMS NIH HHS F32 AR066508NIAMS NIH HHS R01 AR049069
6 · The paper itself

Abstract

Osteolineage cells represent one of the critical bone marrow niche components that support maintenance of hematopoietic stem and progenitor cells (HSPCs). Recent studies demonstrate that extracellular vesicles (EVs) regulate stem cell development via horizontal transfer of bioactive cargo, including microRNAs (miRNAs). Using next-generation sequencing we show that human osteoblast-derived EVs contain highly abundant miRNAs specifically enriched in EVs, including critical regulators of hematopoietic proliferation (e.g., miR-29a). EV treatment of human umbilical cord blood-derived CD34(+) HSPCs alters the expression of candidate miRNA targets, such as HBP1, BCL2 and PTEN. Furthermore, EVs enhance proliferation of CD34(+) cells and their immature subsets in growth factor-driven ex vivo expansion cultures. Importantly, EV-expanded cells retain their differentiation capacity in vitro and successfully engraft in vivo. These discoveries reveal a novel osteoblast-derived EV-mediated mechanism for regulation of HSPC proliferation and warrant consideration of EV-miRNAs for the development of expansion strategies to treat hematological disorders.

Indexed as

AnimalsCell ProliferationCells, CulturedExtracellular VesiclesFemaleFetal BloodHematopoietic Stem CellsHumansMiceMicroRNAsOsteoblastsMicroRNAs

Identifiers

PMID27585950
PMCPMC5009378
OpenAlexW2513669372

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.